echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Chongqing Pharma acquired an 87.47% stake in the subsidiary

    Chongqing Pharma acquired an 87.47% stake in the subsidiary

    • Last Update: 2021-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On December 16, Tiansli announced that it had signed a Framework Agreement with Chongqing Pharmaceuticals (Group) Co., Ltd. ("Chongqing Pharmaceuticals") to sell its controlling subsidiary, Tianjin Tiansli Pharmaceutical Marketing Group Co., Ltd. ("Tiansli Marketing").According to the Agreed Framework, Chongqing Pharma intends to acquire 87.47 percent of Tiansli's direct and indirect stake in Tiansli Marketing and the shares held by Tiansli Marketing's other shareholders by way of cash-for-price.The parties to the transaction intend to determine the final transaction price in consultation with the Asset Assessment Report of the underlying assets as the base date for the assessment of 31 December 2019 (the Underlying Asset Assessment Report will be issued by an asset appraisal institution qualified for securities business).
    (Sina Pharmaceutical News)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.